High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent

Journal of Vascular and Interventional Radiology

Volumn 10, Issue 2 I, 1999, Pages 183-188

  Otal, Philippe ^a   Rousseau, Hervé ^a   Vinel, Jean Pierre ^a   Ducoin, Henri ^a   Hassissene, Sala ^a   Joffre, Francis ^a  

^a CHU RANGUEIL   (France)

Author keywords

Hypertension, portal; Shunts, portosystemic; Stents and prostheses

Indexed keywords

DACRON; POLYVINYL ALCOHOL;

ANGIOGRAPHY; ANIMAL MODEL; ARTICLE; ARTIFICIAL EMBOLISM; FOLLOW UP; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; STENT; SURVIVAL RATE; SWINE;

EID: 0033025147     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(99)70463-X     Document Type: Article

References (27)

1. Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from oesphageal varices. Hepatology 1997; 26:1115-1122.
2. Rössle M, Deibert P, Haag K, et al. Randomised trial of TIPS versus endoscopy plus propanolol for prevention of variceal rebleeding. Lancet 1997; 349:1043-1049.
3. Rousseau H, Vinel JP, El Khoury J, et al. Transjugular intrahepatic portosystemic shunt (TIPS). In: Adam A, Dondelinger RF, Mueller PR, eds. Textbook on metallic stents. Isis Medical Media Ltd, Ox-ford, 1997; 51-70.
4. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugu-lar intrahepatic portosystemic shunts [comment]. Gastroenterology 1997; 112:889-898.
5. LaBerge JM, Ferrell LD, Ring EJ, et al. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. JVIR 1993; 4:779-786.
6. Saxon RR, Mendel-Hartvig J, Coreless CL, et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis of humans and swine. JVIR 1996; 7:487-497.
7. Ducoin H, El Khoury J, Rousseau H, et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology, 1997; 25:1064-1069.
8. Cragg AH, De Jong SC, Barnhart WH, et al. Nitinol intravascular stent: results of preclinical evaluation. Radiology 1993; 189:775-778.
9. Castleman LS, Motzkin SM. The biocompatibility of nitinol. In: Williams DF, ed. Biocompatibility of clinical implants materials. Boca Raton, Fla: CRC Press, 1981.
10. Rousseau H, Gieskes L, Joffre F, et al. Percutaneous treatment of peripheral aneurysms with the Cragg EndoPro System. JVIR 1996; 7:35-39.
11. Palmaz JC, Garcia F, Sibbit RR, et al. Expandable intrahepatic porto-caval shunt stents in dogs with chronic portal hypertension. AJR 1986; 147:1251-1254.
12. Pavcnick D, Saxon RR, Kubota Y, et al. Attempted induction of chronic portal venous hypertension with polyvinyl alcohol particles in swine. JVIR 1997; 8:123-128.
13. Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995; 196:341-347.
14. Golden MA, Hanson SR, Kirkman TR, et al. Healing of PTFE arterial grafts is influenced by graft porosity. J Vasc Surg 1990; 11:838-845.
15. Jerusalem C, Hess F. Healing of coated arterial vascular textile prostheses. In: Christian H, ed. The prosthetic substitution of blood vessels: actual state and future development. München: Quintessenz-Verl.-Gmbh, 1991; 49-56.
16. Zacharias RK, Thomas RK, Clowes MD. Mechanisms of healing in synthetic grafts. J Vase Surg 1887; 6:429-436.
17. Kogel H. Biocompatibility, hemocompatibility and histocompatibility of synthetic blood conduits. In: Christian H, ed. The prosthetic substitution of blood vessels: actual state and future development. München: Quintessenz-Verl.-Gmbh, 1991; 29-36.
18. Greisler HP, Schwarcz TH, Ellinger J, et al. Dacron inhibition of arterial regenerative activities. J Vase Surg 1986; 3:747-756.
19. Schurmann K, Vorwerk D, Uppen-kamp R, Klosterhalfen B, Bucker A, Gunther RW. Iliac arteries: plain and heparin-coated Dacron-covered stent-grafts compared with non covered metal stents - an experimental study. Radiology 1997; 203:55-63.
20. Haskal ZJ, Davis A, McAllister A,Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology 1997; 205:682-688.
21. Maynar M, Reyes R, Ferrai H, et al. Cragg Endopro System 1: early experience. I. Femoral arteries. JVIR 1997; 8:203-207.
22. Marin ML, Veith FJ, Cynamon J, et al. Transfemoral endovascular stented graft treatment of aortoiliac and femoropopliteal occlusive disease for limb salvage. Am J Surg 1994; 168:156-162.
23. Clowes AW , Kirkman TR, Reidy MA. Mechanims of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimai endothelim and smooth muscle in porous PTFE prostheses. Am J Pathol 1986; 123:220-230.
24. Chervu A, Moore WS. An overview of intimai hyperplasia. Surg Gynecol Obstet 1990; 71:433-447.
25. Saxon RR, Timmermans HA, Uchida BT, et al. Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study. JVIR 1997; 8:539-548.
26. Tanihata H, Saxon RR, Kubota Y, et al. Transjugular intrahepatic portosystemic shunt with silicone-covered Wallstents: results in a swine model. Radiology 1997; 205: 181-184.
27. Ferral H, Alcantara-Peraza A, Kimura Y, Castaneda-Zuniga WR. Creation of transjugular intrahepatic portosystemic shunts with use of the Cragg Endopro System I. JVIR 1998; 9:283-287.